Concepedia

Achillion Pharmaceuticals (United States)

AP

125

Publications

11.9K

Citations

30

Authors

New Haven

United States

Achillion Pharmaceuticals (United States) is a company institution in New Haven, United States known for medicine, pharmacology, and drug discovery.

HomepageROR

Top concepts

Publications

125

Antiviral Inhibition of the HIV-1 Capsid Protein

Chun Tang, Erin Loeliger, Isaac Kinde et al. · Journal of Molecular Biology · 2003 · 219 citations

, , +6

Benzamide-Based Thiolcarbamates: A New Class of HIV-1 NCp7 Inhibitors

Atul Goel, Sharlyn J. Mazur, Rasem Fattah et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 119 citations

, , +6

Danicopan: an oral complement factor D inhibitor for paroxysmal nocturnal hemoglobinuria

Antonio M. Risitano, Austin Kulasekararaj, Jong Wook Lee et al. · Haematologica · 2020 · 105 citations · Full text

Small-molecule factor D inhibitors selectively block the alternative pathway of complement in paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

Xuan Yuan, Eleni Gavriilaki, Jane A. Thanassi et al. · Haematologica · 2016 · 98 citations · Full text

Vpu Exerts a Positive Effect on HIV-1 Infectivity by Down-modulating CD4 Receptor Molecules at the Surface of HIV-1-producing Cells

Karine Lévesque, Yongsen Zhao, Éric A. Cohen · Journal of Biological Chemistry · 2003 · 88 citations · Full text

Rows per page

1–5 of 125

Authors

30

PublicationsCitationsH-Index
MJ
Michael J. Pucci

Achillion Pharmaceuticals (United States)

91

3.7K

35

JA
Jane A. Thanassi

Achillion Pharmaceuticals (United States)

51

1.6K

23

JA
Jason A. Wiles

Achillion Pharmaceuticals (United States)

68

1.7K

21

MH
Mingjun Huang

Achillion Pharmaceuticals (United States)

81

2K

19

SD
Steven D. Podos

Achillion Pharmaceuticals (United States)

47

1.1K

19

Rows per page

1–5 of 30